A single dose of topical moxidectin as an effective treatment for murine acariasis due to Myocoptes musculinus

Contemporary Topics in Laboratory Animal Science

Volumn 44, Issue 1, 2005, Pages 26-28

  Pullium, Jennifer K ^a   Brooks, William J ^a   Langley, April D ^a   Huerkamp, Michael K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVERMECTIN; MOXIDECTIN; INSECTICIDE; MACROLIDE; MILBEMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INFESTATION; LARVA; MITE; MOUSE; NONHUMAN; SINGLE DRUG DOSE; ANIMAL; ANIMAL DISEASE; ANIMAL HUSBANDRY; FEMALE; MALE; METHODOLOGY; MOUSE MUTANT; MOUSE STRAIN; PARASITOLOGY; RODENT DISEASE;

ACARI; ANIMALIA; MURINAE; MYOCOPTES;

ANIMAL HUSBANDRY; ANIMALS; FEMALE; INSECTICIDES; MACROLIDES; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MITE INFESTATIONS; MITES; RODENT DISEASES;

EID: 20444504330     PISSN: 10600558     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jacoby, R. O. and J. R. Lindsey. 1998. Risks of infection among laboratory rats and mice at major biomedical research institutions. ILAR J. 39:266-271.
2. Weisbroth, S. H. 1982. Arthropods, p. 385. In H. L. Foster, J. D. Small, and J. G. Fox (ed.), The mouse in biomedical research. Academic Press, New York.
3. Lindsey, J. R., G. A. Boorman, M. J. Collins, et al. 1991. Infectious diseases of rats and mice, p. 179-182. National Research Council, Washington, D.C.
4. Jacoby, R. O., J. G. Fox, and M. Davisson. 2002. Biology and diseases of mice, p. 102-105. In J. G. Fox, L. C. Anderson, F. M. Loew, et al., (ed.), Laboratory animal medicine, 2nd ed. Academic Press, San Diego, Calif.
5. Jungmann, P., J. L. Guenet, P. A. Cazenave, et al. 1996. Marine acariasis. I. Pathological and clinical evidence suggesting cutaneous allergy and wasting syndrome in BALB/c mouse. Res. Immunol. 147:27-38.
6. Jungmann, P., A. Freitas, A. Bandeka, et al. 1996. Murine acariasis. II. Immunological dysfunction and evidence tor chronic activation of Th-2 lymphocytes. Scand. J. Immunol. 43:604-612.
7. Huerkamp, M. J., L. A. Zitzow, S. Webb, et al. Submitted for publication.
8. Burdett, E. C., R. A. Heckmann, and R. Ochoa. 1997. Evaluation of five treatment regimens and five diagnositc methods for murine mites (Myocoptes musculinus and Myobia musculi). Contemp. Top. Lab. Anim. Sci. 36(2):73-76.
9. Wagner, J. E. and D. R. Johnson. 1970. Toxicity of dichlorvos for laboratory mice-LD50 and effect on serum cholinesterase. Lab. Anim. Care 20:45-7.
10. Diggs, H. E., D. J. Feller, J. C. Crabbe, et al. 1990. Effect of chronic ivermectin treatment on GABA receptor function in ethanol with-drawal-seizure prone and resistant mice. Lab. Anim. Sci. 40:68-71.
11. Skopets, B., R. P. Wilson, J. W. Griffith, et al. 1996. Ivermectin toxicity in young mice. Lab. Anim. Sci. 46:111-112.
12. Davis, J. A., R. Paylor, M. P. McDonald, et al. 1999. Behavioral effects of ivermectin in mice. Lab. Anim. Sci. 49:288-296.
13. Conole, J., M. J. Wilkinson, and Q. A. McKellar. 2003. Some observations on the pharmacological properties of ivermectin during treatment of a mite infestation in mice. Contemp. Top. Lab. Anim. Sci. 42(4):42-45.
14. Lok, J. B., D. H. Knight, G. T. Wang, et al. 2001. Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis. Am. J. Vet. Res. 62:1721-1726.
15. Guglielmone, A. A., A. J. Mangold, M. E. Munoz Cobenas, et al. 2000. Moxidectin pour-on for control of natural populations of the cattle tick Boophilus microplus (Acarina: Ixodidae). Vet. Parasitol. 87:237-41.
16. Beco, L., A. Petite, and T. Olivry. 2001. Comparison of subcutaneous ivermectin and oral moxidectin for the treatment of notoedric acariasis in hamsters. Vet. Rec. 149:324-327.
17. Oge, H., E. Ayaz, T. Ide, et al. 2000. The effect of doramectin, moxidectin and netobimin against natural infections of Syphacia muris in rats. Vet. Parasitol. 88:299-303.
18. Molento, M. B. and R. K. Prichard. 1999. Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermecf in or moxidectin against unselected and drug-selected strains of Haernonchus contortus in jirds (Meriones unguiculatus). Parasitol. Res. 85:1007-1011.
19. Small, J. D. 1984. Rodent and lagomorph health surveillance: quality assurance, p. 709-723. In J. G. Fox, B. J. Cohen, and F. M. Loew (ed.), Laboratory animal medicine. Academic Press, Inc., Orlando, Fla.
20. Pong, S. S., C. C. Wang, and E. C. Fritz. 1980. Studies on the mechanism of action of avermectin Bla: stimulation of release of gamma-aminobutyric acid from brain synaptosomes. J. Neurochem. 34:351-358.
21. Paus, R., B. Handjiski, B. M. Czarnetzki, et al. 1994. A marine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A. J. Invest. Dermatol. 103:143-147.
22. Paus, R., C. van der Veen, S. Eichmuller, et al. 1998. Generation and cyclic remodeling of the hair follicle immune system in mice. J. Invest. Dermatol. 111:7-18.
23. Pena, J. C., A. Kelekar, E. V. Fuchs, et al. 1999. Manipulation of outer root sheath cell survival perturbs the hair-growth cycle. EMBO J. 18:3596-3603.
24. Friedman, S. and S. H. Weisbrotli. 1975. The parasitic ecology of the rodent mite Myobia musculi. II. Genetic factors. Lab. Anim. Sci. 25:440-445.